Is Foundayo Safe Long Term? What The Clinical Trial Data Actually Shows
Foundayo (orforglipron) is a once-daily GLP-1 pill FDA-approved on April 1, 2026 for chronic weight management. It is not approved to treat type 2…
April 3, 2026
4 min read